Cargando…

Association of lipid markers with coronary heart disease and stroke mortality: A 15-year follow-up study

OBJECTIVE(S): It has been proposed that lipid markers may predict cardiovascular events; however, their effect may vary depending on the type of cardiovascular disease. The purpose of this study was to investigate the effects of lipid markers on death from coronary heart disease (CHD) and stroke in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pahlavanzade, Bagher, Zayeri, Farid, Baghfalaki, Taban, Mozafari, Omid, Khalili, Davood, Azizi, Fereidoun, Abadi, Alireza
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mashhad University of Medical Sciences 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7038418/ https://www.ncbi.nlm.nih.gov/pubmed/32128098 http://dx.doi.org/10.22038/ijbms.2019.35617.8775

Ejemplares similares

Serum Lipids and Cardiovascular Disease Mortality in Iranian Population: Joint Modeling of Longitudinal and Survival Data in Tehran Lipid and Glucose Study (TLGS) Cohort
por: Pahlavanzade, Bagher, et al.
Publicado: (2019)

Age and aging effects on blood pressure: 15 years follow‐up of Tehran lipid and glucose study
por: Khajavi, Alireza, et al.
Publicado: (2021)

Anthropometric Indices as Predictors of Coronary Heart Disease Risk: Joint Modeling of Longitudinal Measurements and Time to Event
por: GILANI, Neda, et al.
Publicado: (2017)

Different Weight Histories and Risk of Incident Coronary Heart Disease and Stroke: Tehran Lipid and Glucose Study
por: Kabootari, Maryam, et al.
Publicado: (2018)

Obesity Paradox and Recurrent Coronary Heart Disease in a Population-Based Study: Tehran Lipid and Glucose Study
por: Asgari, Samaneh, et al.
Publicado: (2016)

Risk factors for ischemic stroke; results from 9 years of follow-up in a population based cohort of Iran
por: Fahimfar, Noushin, et al.
Publicado: (2012)

Sex specific trajectories of central adiposity, lipid indices, and glucose level with incident hypertension: 12 years Follow-up in Tehran lipid and glucose study
por: Ahanchi, Noushin Sadat, et al.
Publicado: (2021)

Differences in the impact of impaired glucose status on clinical outcomes in younger and older adults: Over a decade of follow-up in the Tehran lipid and glucose study
por: Asgari, Samaneh, et al.
Publicado: (2022)

Validation of the Framingham hypertension risk score in a middle eastern population: Tehran lipid and glucose study (TLGS)
por: Koohi, Fatemeh, et al.
Publicado: (2021)

Patterns of change in obesity indices and other cardiometabolic risk factors before the diagnosis of type 2 diabetes: two decades follow-up of the Tehran lipid and glucose study
por: Koohi, Fatemeh, et al.
Publicado: (2022)

New and known type 2 diabetes as coronary heart disease equivalent: results from 7.6 year follow up in a middle east population
por: Hadaegh, Farzad, et al.
Publicado: (2010)

Sudden cardiac death among Iranian population: a two decades follow-up of Tehran lipid and glucose study
por: Toreyhi, Hossein, et al.
Publicado: (2021)

Underestimating the Effect of Lipids on Cardiovascular Events: Regression Dilution Bias in the Population-Based Cohort of Tehran Lipid and Glucose Study
por: Masudi, Sima, et al.
Publicado: (2015)

Trajectories of cardiovascular disease risk and their association with the incidence of cardiovascular events over 18 years of follow-up: The Tehran Lipid and Glucose study
por: Koohi, Fatemeh, et al.
Publicado: (2021)

Endogenous estrogen exposure and chronic kidney disease; a 15-year prospective cohort study
por: Farahmand, Maryam, et al.
Publicado: (2021)

Sex Specific Incidence Rates of Type 2 Diabetes and Its Risk Factors over 9 Years of Follow-Up: Tehran Lipid and Glucose Study
por: Derakhshan, Arash, et al.
Publicado: (2014)

The relationship between glucose intolerance status and risk of hospitalization during two decades of follow-up: Tehran lipid and glucose study
por: Rasooli, Rahele, et al.
Publicado: (2022)

Factor Structure of the Smoking Temptation Scale: Cross-Validation in Iranian Men
por: Charkazi, Abdurrahman, et al.
Publicado: (2019)

Development and validation of a continuous metabolic syndrome severity score in the Tehran Lipid and Glucose Study
por: Honarvar, Mohammadjavad, et al.
Publicado: (2023)

A new look at risk patterns related to coronary heart disease incidence using survival tree analysis: 12 Years Longitudinal Study
por: Ramezankhani, Azra, et al.
Publicado: (2017)

Sex-Specific Incidence Rates and Risk Factors for Hypertension During 13 Years of Follow-up: The Tehran Lipid and Glucose Study
por: Asgari, Samaneh, et al.
Publicado: (2020)

Incidence and risk factors of severe non‐proliferative/proliferative diabetic retinopathy: More than a decade follow up in the Tehran Lipids and Glucose Study
por: Sardarinia, Mahsa, et al.
Publicado: (2021)

Diabetes Mellitus: Findings from 20 Years of the Tehran Lipid and Glucose Study
por: Ramezankhani, Azra, et al.
Publicado: (2018)

BMI variability and incident diabetes mellitus, Tehran Lipid and Glucose Study (TLGS)
por: Mehran, Ladan, et al.
Publicado: (2022)

Correction To: Sex-Specific Incidence Rates and Risk Factors for Hypertension During 13 Years of Follow-up: The Tehran Lipid and Glucose Study
por: Asgari, Samaneh, et al.
Publicado: (2020)

Robust Modeling of Differential Gene Expression Data Using Normal/Independent Distributions: A Bayesian Approach
por: Ganjali, Mojtaba, et al.
Publicado: (2015)

Twelve-Year Cardiovascular and Mortality Risk in Relation to Smoking Habits in Type 2 Diabetic and Non-Diabetic Men: Tehran Lipid and Glucose Study
por: Hadaegh, Farzad, et al.
Publicado: (2016)

Application of Latent Class Analysis to Identify Metabolic Syndrome Components Patterns in adults: Tehran Lipid and Glucose study
por: Ahanchi, Noushin Sadat, et al.
Publicado: (2019)

Predisposing factors of long-term responsiveness in a cardio-metabolic cohort: Tehran Lipid and Glucose Study
por: Cheraghi, Leila, et al.
Publicado: (2021)

Weight change and risk of cardiovascular disease among adults with type 2 diabetes: more than 14 years of follow-up in the Tehran Lipid and Glucose Study
por: Moazzeni, Seyyed Saeed, et al.
Publicado: (2021)

12-year trends in cardiovascular risk factors (2002-2005 through 2011-2014) in patients with cardiovascular diseases: Tehran lipid and glucose study
por: Rabani, SeyedHossein, et al.
Publicado: (2018)

The risk and added values of the atherosclerotic cardiovascular risk enhancers on prediction of cardiovascular events: Tehran lipid and glucose study
por: Hadaegh, Farzad, et al.
Publicado: (2021)

A 10-Year Cardiovascular Risk in Adults with Different Levels of Spiritual Health: Tehran Lipid and Glucose Study
por: Amiri, Parisa, et al.
Publicado: (2023)

Adolescent lipoprotein classifications according to National Health and Nutrition Examination Survey (NHANES) vs. National Cholesterol Education Program (NCEP) for predicting abnormal lipid levels in adulthood in a Middle East population
por: Hatami, Masumeh, et al.
Publicado: (2012)

Long-term incidence of cardiovascular outcomes in the middle-aged and elderly with different patterns of physical activity: Tehran lipid and glucose study
por: Naseri, Parisa, et al.
Publicado: (2020)

The trend of 10-year cardiovascular risk among diabetic and non-diabetic participants in Tehran Lipid and glucose study: 1999–2018
por: Koohi, Fatemeh, et al.
Publicado: (2022)

Risk of Coronary Heart Events Based on Rose Angina Questionnaire and ECG Besides Diabetes and Other Metabolic Risk Factors: Results of a 10-Year Follow-up in Tehran Lipid and Glucose Study
por: Mansournia, Mohammad Ali, et al.
Publicado: (2017)

Health-related quality of life in men and women who experienced cardiovascular diseases: Tehran Lipid and Glucose Study
por: Jalali-Farahani, Sara, et al.
Publicado: (2021)

The Incidence of Coronary Heart Disease and the Population Attributable Fraction of Its Risk Factors in Tehran: A 10-Year Population-Based Cohort Study
por: Khalili, Davood, et al.
Publicado: (2014)

External validation of the American prediction model for incident type 2 diabetes in the Iranian population
por: Asgari, Samaneh, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ovp31do3sgqon9k74jnke89377